VIA EMAIL ONLY gdion@oharaco.com Ms. Gisele Dion Stoneham MA 02180Director Offer Letter • September 1st, 2022 • Inhibikase Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This Director Offer Letter constitutes an agreement (“Agreement”) between you and Inhibikase Therapeutics, Inc. (“Company”) and contains all of the terms and conditions relating to your service to the Company as a Class II member of our Board of Directors (“Board”).
